Advertisement: Bicycle mid banner
Advertisement: CambridgeTechPodcast midbanner
Advertisement: Featurespace mid banner
Advertisement mid banner S-Tech 3
Advertisement: Cambridge Network mid banner
Advertisement: Alan Boswell Group mid banner
Advertisement: Bar Ellison mid banner property
Advertisement: SATAVIA mid banner
Advertisement: Mogrify mid banner
Advertisement: SourceBioscience mid banner
Advertisement: Wild Knight Vodka
Advertisement: TTP
Cambridgeand mid banner advertisement
Advertisement: Birketts mid banner
Advertisement: Shearline mid banner
Advertisement: Arm mid banner
Advertisement: cofinitive mid banner
Advertisement: RSM mid banner
Advertisement: Marshall mid banner
Advertisement: Ilux mid banner
Advertisement: Evelyn mid banner
Advertisement: Simpsons Creative mid banner
Advertisement: Allia mid banner
Advertisement: CJBS mid banner
Advertisement: SJIP Dirac Building mid-banner
Mid banner advertisement: BDO
Barr Ellison Solicitors – commercial property
13 March, 2023 - 12:17 By Tony Quested

Start date announced for 100,000 sq ft of lab space in Cambridge

Life science companies frustrated by a lack of labs in Cambridge will soon be welcoming the first phase of a dedicated new 100,000 sq ft facility.

Mission Street, a specialist investor, developer and operator for the science and innovation sector, and BentallGreenOak (BGO) have started work to deliver The Press, Foxton in the Cambridge Southern Cluster.

The joint venture is to transform a 7.8-acre site into a science and innovation campus via sensitive re-positioning of a former printing press combined with state of the art new-build.

Uniquely the scheme provides direct rail links to Cambridge Central, Cambridge Biomedical Campus (from 2025) and King’s Cross.

Phase one will comprise the refurbishment of a former printing press, creating 16,000 square feet of fully-fitted lab and office space across two units.

Due for completion in Q3 2023, it will be one of just a handful of life sciences schemes coming online this year. Phase two, which will see the delivery of a newly constructed 65,000 sq ft building, is due to complete in summer 2024.

According to market data tracked by Mission Street, there is demand for over one million square feet of lab space in Cambridge; only 10,000 is currently available.

The Mission Steet-BGO joint venture has a development pipeline of over one million square feet of lab and office space in key strategic locations. Today’s announcement follows news that the joint venture has acquired a 23-acre site to the east of Central Cambridge, where it plans to create an urban  science and innovation district that will serve the region’s promising start-ups and scale-ups.

Artem Korolev, founder and CEO of Mission Street, commented: “As part of our plans for The Press, we are bringing much-needed purpose-built life science space online quickly into market that is suffering from an acute
shortage of stock. 

“Britain’s life sciences sector is at an inflection point and to fully realise the potential of our world-leading research and discovery, we must focus on providing the facilities that will enable our burgeoning R & D ecosystem to scale and commercialise.  

“Our plans for the Press have been developed through extensive and overwhelmingly positive engagement with the local community and key stakeholders. 

“We now look forward to delivering a design-led scheme that will be an attractive addition to the Cambridge ecosystem and continuing to engage with some incredibly exciting occupiers in supporting their growth.”

Newsletter Subscription

Stay informed of the latest news and features